Literature DB >> 17097209

An observational study of vasopressin infusion during uncontrolled haemorrhagic shock in a porcine trauma model: Effects on bowel function.

Karl H Stadlbauer1, Volker Wenzel, Horst G Wagner-Berger, Anette C Krismer, Alfred Königsrainer, Wolfgang G Voelckel, Claus Raedler, Christian A Schmittinger, Karl H Lindner, Guenter Klima.   

Abstract

The effects of vasopressin on the gut in a porcine uncontrolled haemorrhagic shock model are described. In eight anaesthetised pigs, a liver laceration was performed; when haemorrhagic shock was decompensated, all animals received 0.4 IU/kg vasopressin, followed by 0.08 IU/kg min over 30 min, which maintained a mean arterial blood pressure >40 mmHg. Subsequent surgical intervention, infusion of whole blood and fluids resulted in a stable cardiocirculatory status. Three hours after stabilisation, all pigs developed non-bloody diarrhoea which converted into normal bowel movements within 24 h. All histological samples retained 7 days after the experiment revealed no histopathological changes. In conclusion, in this small observational study of uncontrolled porcine haemorrhagic shock, a resuscitation strategy that included high dose vasopressin was associated with transient diarrhoea and good long term survival.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17097209     DOI: 10.1016/j.resuscitation.2006.06.022

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  2 in total

1.  Evaluation of capillary leakage after vasopressin resuscitation in a hemorrhagic shock model.

Authors:  Roberto Bini; Osvaldo Chiara; Stefania Cimbanassi; Giorgio Olivero; Antonella Trombetta; Paolo Cotogni
Journal:  World J Emerg Surg       Date:  2018-03-05       Impact factor: 5.469

2.  A treatment protocol including vasopressin and hydroxyethyl starch solution is associated with increased rate of return of spontaneous circulation in blunt trauma patients with pulseless electrical activity.

Authors:  Stefek Grmec; Matej Strnad; Darko Cander; Stefan Mally
Journal:  Int J Emerg Med       Date:  2008-11-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.